lenalidomide has been researched along with Ambulation Disorders, Neurologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Steck, AJ | 1 |
Sucak, GT; Suyanı, E; Yağcı, M | 1 |
1 review(s) available for lenalidomide and Ambulation Disorders, Neurologic
Article | Year |
---|---|
Anti-MAG neuropathy: From biology to clinical management.
Topics: Adenine; Animals; Autoantibodies; Autoantigens; B-Lymphocyte Subsets; CD57 Antigens; Demyelinating Autoimmune Diseases, CNS; Epitopes; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Immunotherapy; Lenalidomide; Mammals; Mice; Molecular Mimicry; Myelin Sheath; Myelin-Associated Glycoprotein; Nerve Fibers, Myelinated; Nervous System Autoimmune Disease, Experimental; Paraproteinemias; Paraproteins; Piperidines; Plasma Exchange; Polyradiculoneuropathy; Ranvier's Nodes; Rats; Rituximab | 2021 |
1 other study(ies) available for lenalidomide and Ambulation Disorders, Neurologic
Article | Year |
---|---|
Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gait Disorders, Neurologic; Glucocorticoids; Hand Deformities, Acquired; Humans; Lenalidomide; POEMS Syndrome; Prednisolone; Proteasome Inhibitors; Remission Induction; Thalidomide; Vascular Endothelial Growth Factors | 2011 |